IITF 2026 - EPFO Lounge & ESIC Pavilion inaugurated (See 'Corp Brief') Giriraj Singh visits Welspun World's State-of-the-Art Manufacturing Units in Kutch (See 'Corp Brief') PMLA - Status of secured creditor & initiation of prior recovery proceedings under SARFAESI Act do not exempt a property from attachment under PMLA, when property constitutes proceeds of crime: SAFEMA Tribunal (See 'Legal Desk') Indian Business leaders and Start ups to participate in the India-Egypt Business Forum (See 'Corp Brief') NRIDA selected for Medal for Innovation in Road Technology (See 'Corp Brief') PMLA - Objectives of special anti-money laundering law supersede private commercial security interests - properties linked to criminal activities liable to provisional & final attachment: SAFEMA Tribunal (See 'Legal Desk') Shilp Samagam Mela 2026 at Dilli Haat records Cumulative Sales of Over Rs 88.36 Lakh (See 'Corp Brief') National Tribal Literary Festival concludes with Emphasis on Preserving Oral Traditions (See 'Corp Brief') SEBI - Freezing the Appellants' demat & bank accounts pending deposit of alleged unlawful gains of Rs. 28.12 crore, is valid: SAT (See 'Legal Desk') MoS calls for strengthening India-Italy collaborative research for innovation (See 'Corp Brief') Ministry of Culture invites Partners to Build India's Creative Economy Together (See 'Corp Brief') DoT organises First All India Conference on Official Language 2026 in New Delhi (See 'Corp Brief') Centre strengthens healthcare network through 3 Urban Primary Health Centres (See 'Corp Brief') TDB-DST signs agreement with Astrome to develop sovereign space-based AI-ELINT constellation (See 'Corp Brief') 2nd Edition of the National Tribal Literary Festival 2026 begins in New Delhi (See 'Corp Brief') CCRAS-CARI and University of Delhi sign MoU to document medicinal plant diversity (See 'Corp Brief') RTI - Per Sections 2 & 3 of the Act, CPIO is not obligated to compile, analyze, correlate, or generate fresh datasets from disparate records in specific format desired by applicant: IBBI (See 'Legal Desk') Naturopathy Day 2026: Scientific Research strengthens India's Nature-Based Healthcare Ecosystem (See 'Corp Brief') India and Italy to deepen scientific cooperation through bilateral engagements (See 'Corp Brief') Yadav holds interaction with LeadIT Industry Members and Project Partners (See 'Corp Brief') SEBI - Stay on 5-year debarrment unwarranted where Appellant fails to make out prima facie case - unusual trading pattern noted along with admitted receipt of certain funds from connected entities: SAT (See 'Legal Desk') India strengthens Regional Health Partnerships as First BIMSTEC summit (See 'Corp Brief') CBN dismantles clan lab of mephedrone in Uttar Pradesh (See 'Corp Brief') IPR - Dominant element of composite mark is entitled to standalone protection and party cannot resile from concession made on court record without seeking formal recall of order: HC (See 'Legal Desk') An unsuccessful 'success fee' litigation (See CORP EINSICHT)

Pharmaceuticals & Medical Devices Bureau has partnered to open Jan Aushadhi Kendras

Published: Dec 11, 2024

By TIOLCorplaws News Service

NEW DELHI, DEC 11, 2024: TO increase access to medicines in rural areas, the Pharmaceuticals & Medical Devices Bureau of India, the implementing agency of PMBJP has partnered with the Cooperative sector to open Jan Aushadhi Kendras through Primary Agriculture Cooperative Societies (PACS). Till 30th November 2024, more than 2690 PACS have been given initial approval and 687 Kendras have been opened in PACS.

The government launched Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) under which Jan Aushadhi Kendras (JAKs) are opened by inviting applications from individual entrepreneurs, NGOs, Societies, Trusts, Firms, and Private Companies etc. While opening these Kendras, 1 km distance is maintained between two Kendras. Online applications have been invited from all districts through the website www.janaushadhi.gov.in. This process facilitates opening of Jan Aushadhi Kendras (JAKs) at the block as well as at the district level. There is no State/UT-wise target for opening of new JAKs.

Jan Aushadhi medicines are being supplied to Central Government Health Scheme dispensaries, various AIIMS, Hospitals, etc. based on their demand. All JAK owners are eligible for an incentive @ 20% of monthly purchases made by them, subject to a ceiling of Rs. 20,000/- per month. In addition, a one-time incentive of Rs. 2.00 lakh is provided to the JAKs opened in North-Eastern States, Himalayan areas, Island territories, and areas mentioned as aspirational districts by NITI Aayog or opened by women entrepreneurs, ex-servicemen, Divyang, SC & ST in the form of support towards furniture, computers, refrigerators, and other fixtures. For operational support, there are State-wise Marketing Officers who support applicants in obtaining Drug licenses and supply of medicines to JAKs by the distributor and warehouse network of Jan Aushadhi.

This information was given by the Union Minister of State for Chemicals and Fertilizers Anupriya Patel in Rajya Sabha in a written reply to a question yesterday.

TIOL CORP SEARCH

TIOL GROUP WEBSITES